- 3
- 0
- 约1.05万字
- 约 39页
- 2022-03-20 发布于广东
- 举报
Lipid management In the majority of patients this is achievable through statin monotherapy. Other interventions (e.g. fibrates, resins, nicotinic acid, ezetimibe) may lower LDL cholesterol but no benefit on clinical outcomes has been reported for these alternatives. Although elevated levels of triglycerides and low HDL cholesterol (HDL-C) are associated with increased CVD risk, clinical trial evidence is insufficient to specify treatment targets, which should be regarded as not indicated. 现在二十八页,总共三十九页。 Lipid management For patients undergoing PCI for SCAD, high dose atorvastatin has bee
原创力文档

文档评论(0)